Menu

实习

The following Incubator/BioBAT companies have internships available for qualified 候选人. Please contact the organization for details regarding their openings.

Applied Biological Laboratories Inc.

Applied Biological Laboratories Inc. is a biotechnology company committed to research, development, manufacturing and distribution of scientifically validated natural products.


联系人: Nazlie Latefi, PhD

appliedbioinc.com


Biotia公司.

Biotia is a health tech company, launched from Cornell Tech and Weill Cornell Medicine, that leverages DNA sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. 他们的 mission is to fight infectious disease by deploying the leading reference library of microbes worldwide.


联系人: 考特尼海格

biotia.io/suny-internships


International AIDS Vaccine Initiative (IAVI) , Inc.

IAVI's Vaccine Design and Development Laboratory (DDL) is a versatile facility designed to create novel immunogens, develop viral vectors, evaluate potency and advance promising 候选人 to clinical evaluation. The DDL has also established common preclinical standards for the vaccine field. 他们的 goals are to understand the basis of naturally evoked, broadly neutralizing antibodies against HIV and other Emerging Infectious Diseases (EID) such as, but not limited to, Lassa fever, Marburg virus, and Covid-19.


联系人: Joanne De Stefano

iavi.org


Interstate Environmental Commission

The Interstate Environmental Commission (IEC) is a tri-state water and air pollution control agency committed to protecting, conserving, and restoring the environment in the Interstate Environmental District, particularly in the area of water quality. IEC seeks to achieve this goal through cooperation, regulation, coordination, and mutual dialogue between government and citizens in the Tri-State Region.


联系人: 伊芙琳的权力

iec-nynjct.org/join


Mirimus公司.

Mirimus is a high-tech business with the expertise in RNAi technologies required for development of superior tools for potent gene silencing, both in cells and animal 模型. Its advanced RNAi technologies are critical for the generation of animal 模型 that can pave the way drugs are developed by pin-pointing potential toxicities and preventing harmful side-effects of therapeutics in patients. Mirimus is also engaged in the design, development and pioneering of new CRISPR/Cas9 genome editing technologies to develop advanced human disease 模型 that are crucial for the preclinical evaluation of new therapeutics.


联系人: 米玛Kovacevic

mirimus.com